Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bridgewater, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Amneal Pharmaceuticals, Inc. has filed 691 SEC EDGAR filings since 21 Nov 2017

SEC filing history

Showing 651-675 of 691 matching filings.

Per page
25
Current page
27
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
08 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-224702

FORM S-1

Filing date
07 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-223501

RW

Filing date
07 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-224700

S-8

Filing date
07 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38485

8-K

Filing date
07 May 2018
Reporting date
04 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38485

FORM 8-K

Filing date
07 May 2018
Reporting date
07 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-38485

NYSE CERTIFICATION - AMNEAL PHARMACEUTICALS, INC.

Filing date
04 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-38485

8-A12B

Filing date
04 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-223501

AMENDMENT NO. 1 TO FORM S-1

Filing date
13 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-223501

S-1

Filing date
07 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .